Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status

Pocock, 2006, Predictors of mortality and morbidity in patients with chronic heart failure, Eur Heart J, 27, 65, 10.1093/eurheartj/ehi555 Yancy, 2006, Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database, J Am Coll Cardiol, 47, 76, 10.1016/j.jacc.2005.09.022 Mogensen, 2017, Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction, J Am Coll Cardiol, 70, 2490, 10.1016/j.jacc.2017.09.027 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039 Lee, 2018, Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder, Heart Rhythm, 15, 287, 10.1016/j.hrthm.2017.09.009 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Odutayo, 2016, Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis, BMJ, 354, i4482, 10.1136/bmj.i4482 Healey, 2016, Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study, Lancet, 388, 1161, 10.1016/S0140-6736(16)30968-0 Vermond, 2015, Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands, J Am Coll Cardiol, 66, 1000, 10.1016/j.jacc.2015.06.1314 Wong, 2018, Progression of device-detected subclinical atrial fibrillation and the risk of heart failure, J Am Coll Cardiol, 71, 2603, 10.1016/j.jacc.2018.03.519 Olsson, 2006, Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program, J Am Coll Cardiol, 47, 1997, 10.1016/j.jacc.2006.01.060 Swedberg, 2005, Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET, Eur Heart J, 26, 1303, 10.1093/eurheartj/ehi166 Aleong, 2014, New-onset atrial fibrillation predicts heart failure progression, Am J Med, 127, 963, 10.1016/j.amjmed.2014.06.006 Carlisle, 2019, Heart failure and atrial fibrillation, like fire and fury, J Am Coll Cardiol HF, 7, 447 Boehmer, 2017, A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study, J Am Coll Cardiol HF, 5, 216 Gardner, 2018, HeartLogic multisensor algorithm identifies patients during periods of significantly increased risk of heart failure events: results from the MultiSENSE study, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.117.004669 Capucci, 2019, Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report, ESC Heart Fail, 6, 308, 10.1002/ehf2.12394 Boehmer, 2015, Rationale and design of the Multisensor Chronic Evaluations in Ambulatory Heart Failure Patients (MultiSENSE) study, J Innov Card Rhythm Manag, 6, 2137 Healey, 2012, Subclinical atrial fibrillation and the risk of stroke, N Engl J Med, 366, 120, 10.1056/NEJMoa1105575 Van Gelder, 2017, Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT, Eur Heart J, 38, 1339, 10.1093/eurheartj/ehx042 Gorenek, 2017, Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Lat, Europace, 19, 1556, 10.1093/europace/eux163 Wong, 2020, Modifiable risk factors predict incident atrial fibrillation and heart failure, Open Heart, 7, 1, 10.1136/openhrt-2019-001092 Kotecha, 2016, Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins, J Am Coll Cardiol, 68, 2217, 10.1016/j.jacc.2016.08.048 Verma, 2017, Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction, Circulation, 135, 1547, 10.1161/CIRCULATIONAHA.116.026054 Benjamin, 1994, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study, JAMA, 271, 840, 10.1001/jama.1994.03510350050036 Sartipy, 2017, Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction, J Am Coll Cardiol HF, 5, 565 Cao, 2019, Ambulatory monitoring of heart sounds via an implanted device is superior to auscultation for prediction of heart failure events, J Card Fail, 26, 151, 10.1016/j.cardfail.2019.10.006 January, 2014, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol, 64, e1, 10.1016/j.jacc.2014.03.022 Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 62, e147, 10.1016/j.jacc.2013.05.019 Marrouche, 2018, Catheter ablation for atrial fibrillation with heart failure, N Engl J Med, 378, 417, 10.1056/NEJMoa1707855